{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:45:16Z","timestamp":1778507116723,"version":"3.51.4"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,8]]},"DOI":"10.18632\/oncotarget.12316","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T20:55:59Z","timestamp":1475096159000},"page":"74107-74119","source":"Crossref","is-referenced-by-count":29,"title":["Immune adjuvant effect of a<i>Toxoplasma gondii<\/i>profilin-like protein in autologous whole-tumor-cell vaccination in mice"],"prefix":"10.18632","volume":"7","author":[{"given":"Kyoung-Ho","family":"Pyo","sequence":"first","affiliation":[{"name":"Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine and Institute of Endemic Diseases, Seoul National University Medical Research Center, Seoul, Republic of Korea"},{"name":"Current address: JE-UK Laboratory of Molecular Cancer Therapeutics, Yonsei Cancer Institute, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine and Institute of Endemic Diseases, Seoul National University Medical Research Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Min","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Hee","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine and Institute of Endemic Diseases, Seoul National University Medical Research Center, Seoul, Republic of Korea"},{"name":"Seoul National University Bundang Hospital, Seongnam, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"key":"1","first-page":"132","article-title":"Selected anti-tumor vaccines merit a place in multimodal tumor therapies","volume":"2","author":"Frey","year":"2012","journal-title":"Frontiers in oncology"},{"key":"2","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-09-4480","article-title":"4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines","volume":"70","author":"Shirwan","year":"2010","journal-title":"Cancer research"},{"key":"3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mt.2010.268","article-title":"DAI (DLM-1\/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity","volume":"19","author":"Ljungberg","year":"2011","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1586\/14760584.2014.911093","article-title":"Various ways to improve whole cancer cell vaccines","volume":"13","author":"Sanders","year":"2014","journal-title":"Expert review of vaccines"},{"key":"5","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.4161\/21645515.2014.982996","article-title":"Tumor cell lysates as immunogenic sources for cancer vaccine design","volume":"10","author":"Salazar-Onfray","year":"2014","journal-title":"Human vaccines & immunotherapeutics"},{"key":"6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2177\/jsci.39.51","article-title":"The effects of TGF-betas on immune responses","volume":"39","author":"Fujio","year":"2016","journal-title":"Nihon Rinsho Men'eki Gakkai kaishi"},{"key":"7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Kronenberg","year":"2009","journal-title":"Nature immunology"},{"key":"8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/21645515.2015.1009814","article-title":"Clinically feasible approaches to potentiating cancer cell-based immunotherapies","volume":"11","author":"Seledtsova","year":"2015","journal-title":"Human vaccines & immunotherapeutics"},{"key":"9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.0408228","article-title":"Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy","volume":"88","author":"Grabbe","year":"2010","journal-title":"Journal of leukocyte biology"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Abdul-Cader, Amarasinghe, Abdul-Careem. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Archives of virology. 2016.","DOI":"10.1007\/s00705-016-2904-x"},{"key":"11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chom.2008.01.001","article-title":"Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response","volume":"3","author":"Soldati-Favre","year":"2008","journal-title":"Cell Host Microbe"},{"key":"12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1159\/000362367","article-title":"Toxoplasma gondii- derived profilin triggers human toll-like receptor 5-dependent cytokine production","volume":"6","author":"Aliberti","year":"2014","journal-title":"J Innate Immun"},{"key":"13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2012.09.016","article-title":"Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii","volume":"38","author":"Ghosh","year":"2013","journal-title":"Immunity"},{"key":"14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/vaccines2020323","article-title":"Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands","volume":"2","author":"Massari","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0264-410X(02)00599-6","article-title":"Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R)","volume":"21","author":"Mason","year":"2003","journal-title":"Vaccine"},{"key":"16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11060-008-9693-3","article-title":"A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)","volume":"91","author":"Prados","year":"2009","journal-title":"J Neurooncol"},{"key":"17","first-page":"640","article-title":"Phase I trials of poly(I,C) complexes in advanced cancer","volume":"4","author":"Oettgen","year":"1985","journal-title":"J Biol Response Mod"},{"key":"18","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.4049\/jimmunol.0900974","article-title":"TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination","volume":"183","author":"Dong","year":"2009","journal-title":"J Immunol"},{"key":"19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/pros.20941","article-title":"Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer","volume":"69","author":"Stenzl","year":"2009","journal-title":"Prostate"},{"key":"20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/CJI.0b013e318174a4df","article-title":"Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma","volume":"31","author":"Trefzer","year":"2008","journal-title":"J Immunother"},{"key":"21","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2012.43.7111","article-title":"Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma","volume":"31","author":"Brichard","year":"2013","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/bjc.2013.227","article-title":"Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours","volume":"108","author":"Mather","year":"2013","journal-title":"Br J Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.2005.06486.x","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe","volume":"152","author":"McRae","year":"2005","journal-title":"Br J Dermatol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.gt.3302559","article-title":"Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2\/neu-positive mammary carcinoma","volume":"12","author":"Provinciali","year":"2005","journal-title":"Gene Ther"},{"key":"25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CJI.0b013e3181f1d614","article-title":"Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients","volume":"33","author":"Romero","year":"2010","journal-title":"J Immunother"},{"key":"26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/gut.2010.223891","article-title":"Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity","volume":"60","author":"Neish","year":"2011","journal-title":"Gut"},{"key":"27","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.vaccine.2013.06.054","article-title":"Flagellin enhances tumor-specific CD8(+) T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model","volume":"31","author":"Rhee","year":"2013","journal-title":"Vaccine"},{"key":"28","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Sher","year":"1994","journal-title":"J Immunol"},{"key":"29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3347\/kjp.2010.48.2.171","article-title":"Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB\/c mice","volume":"48","author":"Shin","year":"2010","journal-title":"Korean J Parasitol"},{"key":"30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3347\/kjp.2014.52.6.605","article-title":"Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment","volume":"52","author":"Shin","year":"2014","journal-title":"Korean J Parasitol"},{"key":"31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"Weiss","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/IR:36:1:137","article-title":"Helper roles of NK, CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines","volume":"36","author":"Mailliard","year":"2006","journal-title":"Immunologic research"},{"key":"33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nature reviews Immunology"},{"key":"34","first-page":"687","article-title":"An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth","volume":"2","author":"Thomas-Tikhonenko","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.2174\/092986710793176366","article-title":"Anticancer properties of the IL-12 family--focus on colorectal cancer","volume":"17","author":"Neurath","year":"2010","journal-title":"Curr Med Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0100-879X2011000600003","article-title":"Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants","volume":"44","author":"Ho","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.4161\/hv.29857","article-title":"Dendritic cell defects in the colorectal cancer","volume":"10","author":"Spisni","year":"2014","journal-title":"Human vaccines & immunotherapeutics"},{"key":"39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09273940600943581","article-title":"Dynamic expression of chemokines and the infiltration of inflammatory cells in the HSV-infected cornea and its associated tissues","volume":"14","author":"Miyasaka","year":"2006","journal-title":"Ocular immunology and inflammation"},{"key":"40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/ATVBAHA.114.303227","article-title":"Lymphocyte migration into atherosclerotic plaque","volume":"35","author":"Ley","year":"2015","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"Journal of leukocyte biology"},{"key":"42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00281-004-0167-1","article-title":"Dendritic cell-mediated T cell polarization","volume":"26","author":"Kapsenberg","year":"2005","journal-title":"Springer seminars in immunopathology"},{"key":"43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1359-6101(00)00010-1","article-title":"Interferon-gamma and interleukin-12 pathway defects and human disease","volume":"11","author":"Holland","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3347\/kjp.2011.49.2.115","article-title":"Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responses","volume":"49","author":"Shin","year":"2011","journal-title":"The Korean journal of parasitology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T08:12:27Z","timestamp":1692519147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,28]]},"references-count":44,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2016,11,8]]}},"alternative-id":["12316","27687589"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12316","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,28]]}}}